Zosyn and Gaviscon drug interactions - a phase IV clinical study of FDA data
Summary:
The phase IV clinical study analyzes what interactions people have when they take Zosyn and Gaviscon. It is created by eHealthMe based on reports of 5 people who take the same drugs from the FDA, and is updated regularly.
What is Zosyn?
Zosyn has active ingredients of piperacillin sodium; tazobactam sodium. It is often used in pneumonia. eHealthMe is studying from 10,236 Zosyn users. Check the latest studies of Zosyn.
What is Gaviscon?
Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,354 Gaviscon users. Check the latest studies of Gaviscon.
5 people who take Zosyn and Gaviscon together, and have interactions are studied.
What are the common drug interactions of Zosyn and Gaviscon, by gender? *:
female:
- Adhesion
- Arteriosclerosis (thickening and hardening of arteries)
- Asthenia (weakness)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Breath sounds
- Cardiac failure
- Cardiac murmur (an heart sound in valve abnormality)
- Carotid artery stenosis (narrowing of carotid artery)
- Carotid bruit (sound heard over the carotid artery area during auscultation)
- Chest pain
male:
- Chronic kidney disease
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
What are the common drug interactions of Zosyn and Gaviscon, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Chronic kidney disease
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
60+:
- Chronic kidney disease
* Approximation only. Some reports may have incomplete information.
Do you take Zosyn and Gaviscon?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Zosyn and Gaviscon:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zosyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Gaviscon:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zosyn and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gaviscon and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on piperacillin sodium; tazobactam sodium and aluminum hydroxide; magnesium trisilicate (the active ingredients of Zosyn and Gaviscon, respectively), and Zosyn and Gaviscon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Transient Ischaemic Attack and drugs of ingredients of ethinyl estradiol; norethindrone acetate - 3 seconds ago
- Simvastatin and Pain - Eye for Men aged 50-59 - 6 seconds ago
- Simvastatin and Ophthalmalgia for Men aged 50-59 - 7 seconds ago
- Simvastatin and Eye Pain for Men aged 50-59 - 7 seconds ago
- Colace and Nonspecific Back Pain for Men aged 60+ - 15 seconds ago
- Colace and Pain - Back for Men aged 60+ - 15 seconds ago
- Colace and Back Pain - Nonspecific for Men aged 60+ - 15 seconds ago
- Colace and Back Pain for Men aged 60+ - 16 seconds ago
- Tooth Loss and drugs of ingredients of marijuana - 16 seconds ago
- Could Tazorac cause Hypothyroidism? - 17 seconds ago